The Centers for Disease Control and Prevention (CDC) has reversed its initial stance on handling American Ebola patients, now considering bringing them to the U.S. for treatment. Acting CDC Director Jay Bhattacharya stated on June 3 that officials are no longer ruling out transporting exposed individuals to the U.S. if intensive care is required. This marks a departure from earlier plans to quarantine Americans at risk of Ebola in a facility in Kenya.
Bhattacharya defended the administration’s Ebola response, contrasting it with COVID-19 measures. In a Wall Street Journal op-ed, he argued that Ebola containment efforts—such as travel restrictions and targeted quarantines—are scientifically justified due to the virus’s high mortality rate and known transmission methods. The administration imposed entry bans on non-U.S. passport holders traveling from Congo, Uganda, and South Sudan, requiring them to spend 21 days elsewhere before entering the U.S.
Critics, including the Infectious Diseases Society of America (IDSA), disputed the effectiveness of border closures, arguing that viruses do not recognize passports and that such policies disproportionately target immigrants. The IDSA emphasized that public health measures should not single out non-citizens, as they do not prevent viral spread.
The CDC’s initial plan to quarantine exposed Americans in Kenya drew controversy. Bhattacharya defended the facility, stating it provided ICU-level care and quarantine capacity. However, the recent shift suggests a reevaluation of the approach, prioritizing domestic treatment for severe cases.
The administration’s Ebola response has sparked debate over public health strategies, with some praising its targeted measures and others criticizing its focus on immigration restrictions.